Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Punjab Government and Ananya Birla Foundation launch DITSU to strengthen drug abuse response
Data Intelligence and Technical Support Unit to support evidence-based strategies, enforcement coordination, and community…
Kashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue…
Ahmedabad-based pharma company outlines investment and export strategies, automation upgrades, and long-term diversification into…
University of East Anglia and King’s College London release guidance for GPs managing patients using…
New recommendations aim to support primary care professionals as private use of GLP-1 medications such as Mounjaro and Ozempic…
Lupin launches Prucalopride Tablets in the US market post FDA approval
Lupin begins US sales of Prucalopride Tablets, bioequivalent to Takeda’s Motegrity, for chronic idiopathic constipation treatment
Sudeep Pharma files DRHP with SEBI for IPO to raise ₹95 Crore
The company files DRHP with SEBI to raise funds via IPO
Bharat Biotech and GSK pledge to lower malaria vaccine price under Gavi replenishment initiative
RTS,S vaccine price to be reduced to below $5 by 2028 through manufacturing scale-up and technology transfer
Lupin receives approval from US FDA for Prucalopride Tablets
The approved tablets are bioequivalent to Takeda’s Motegrity and will be manufactured at Lupin’s Goa facility
Yeztugo holds potential to address key unmet needs for PrEP usage including adherence issues:…
Twice-yearly injectable therapy may improve adherence and expand access to HIV prevention, but affordability and insurance…
Utopia Therapeutics secures $1.5 million seed funding from whale tank to advance obesity vaccine…
Investment will accelerate preclinical development of UT009 and support early-stage trials for novel immunotherapeutic targeting…
Novo Nordisk launches Wegovy for chronic weight management and cardiovascular risk reduction in…
Wegovy, a once-weekly semaglutide injection, is reportedly the first GLP-1 receptor agonist in India approved for both long-term…